-
Six billion oseltamivirs, two competing items
Time of Update: 2020-05-28
Nearly 6 billion oseltamivir markets, two competing products reported recently, Chengdu Cente 3 generic drug "phosphate oseltamivir dry suspension" listed application by the Drug Review Center (CDE)
-
Here comes the big policy! Chinese Herbal Pieces added true to be cancelled
Time of Update: 2019-12-17
[pharmaceutical network industry trends] the reform of China's medical system has been advancing Drug reform is an important part of medical reform The cancellation of drug addition will have a profou
-
The total amount of review has reached 436 and passed another batch: metformin, Cefalexin
Time of Update: 2019-11-28
Source: announcement of listed pharmaceutical companies ▍ finishing: Cypress blue corn Another batch of drugs has been evaluated, and the total number has reached 436 On November 28, the State Council
-
"Pharmaceutical leader" market leading policy of basic drugs, red bag Novo Nordisk Q3, China market growth 17
Time of Update: 2019-11-06
Policy review of the pilot cities of the top 10 clinics; Zhengda Tianqing's fourth generation EGFR-TKI enters the clinical practice to overcome the drug resistance problem of oxitinib; Fosun Pharmaceutical's "spin off" action in further gland Pharma plans to be listed in India Great!
-
[good medicine record] weekly trend of consistency evaluation: the first evaluation of 10 billion market-oriented varieties, 5 drugs in the near future, 12 drugs accepted
Time of Update: 2019-06-10
As of June 6, 1166 acceptance numbers (348 varieties of 365 enterprises, calculated according to supplementary application, the same below) of CDE's acceptance numbers have passed the consistency eval
-
Public consultation on the determination of bacteriostatic in eye drops
Time of Update: 2018-03-29
[policies and regulations of chinapharma.com] on March 28, the State Pharmacopoeia Committee publicly solicited opinions on the method for the determination of bacteriostatic agents in eye drops (Draf
-
Analysis of China's pharmaceutical industry in 2016 with three network buzzwords
Time of Update: 2016-11-01
[editor's point of view of chinapharma.com] unconsciously, it has entered November, and in an instant, it has come to the end of 2016 Has anyone begun to count down? At the end of the year, every majo
-
CFDA: Notice on strengthening the supervision and management of extraction and extraction in the production of traditional Chinese Medicine
Time of Update: 2014-08-05
Sfjyhj [2014] No 135: the approval of the entrusted processing of extraction of traditional Chinese medicine will be stopped from the date of issuance of the notice If it has been approved, it can con
